SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Guardian Pharmacy Services, Inc.
Date: May 20, 2025 · CIK: 0001802255 · Accession: 0001193125-25-123192

Offering / Registration Process Regulatory Compliance Business Model Clarity

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287431

Date
May 20, 2025
Author
Frank Hancock
Form
CORRESP
Company
Guardian Pharmacy Services, Inc.

Letter

Re: Guardian Pharmacy Services, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-287431 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “ Securities Act ”), and as representative of the several underwriters of the proposed public offering by the Company and certain selling stockholders, we hereby join with the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 p.m., Eastern time, on May 22, 2025, or as soon thereafter as is practicable, or at such later time as the Company or its legal counsel, Jones Day, may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Pursuant to Rule 460 under the Securities Act, please be advised that we, as representative of the several underwriters, will take reasonable steps to secure adequate distribution of the preliminary prospectus dated May 20, 2025, to prospective underwriters, dealers, institutional investors and others, prior to the requested effective time of the Registration Statement. We, the undersigned, as representative of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

May 20, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549

Very truly yours,
RAYMOND JAMES & ASSOCIATES, INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 May 20, 2025
 VIA EDGAR United States Securities and
Exchange Commission Division of Corporation Finance 100 F
Street, N.E. Washington, D.C. 20549

 Re:
 Guardian Pharmacy Services, Inc. (the “Company”)
 Registration Statement on Form S-1
 File No. 333-287431 Ladies and Gentlemen:
 In accordance with Rule 461 under the Securities Act of 1933, as amended (the “ Securities Act ”), and as
representative of the several underwriters of the proposed public offering by the Company and certain selling stockholders, we hereby join with the Company’s request that the effective date of the above-referenced Registration Statement be
accelerated so that the same will become effective at 4:00 p.m., Eastern time, on May 22, 2025, or as soon thereafter as is practicable, or at such later time as the Company or its legal counsel, Jones Day, may orally request via telephone call
to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Pursuant to Rule 460 under the
Securities Act, please be advised that we, as representative of the several underwriters, will take reasonable steps to secure adequate distribution of the preliminary prospectus dated May 20, 2025, to prospective underwriters, dealers,
institutional investors and others, prior to the requested effective time of the Registration Statement. We, the undersigned, as
representative of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule
 15c2-8 under the Securities Exchange Act of 1934, as amended.

 Very truly yours,

 RAYMOND JAMES & ASSOCIATES, INC.

 By:

 /s/ Frank Hancock

 Name: Frank Hancock

 Title: Managing Director